It has been my privilege to participate in the development and introduction of many new GI technologies, which give gastroenterologists the ability to do so much more for patients. My work with innovating GI procedures started during my fellowship and continued throughout my career. I trust you will also enjoy remembering how some procedures and technologies have come and gone, while others have become commonplace.
In the early 1980s, Dr. Reed Hogan II and I began to do a procedure called endoscopic percutaneous gastrostomy, which had begun in 1979. As part of its development, I changed the name to percutaneous endoscopic gastrostomy, and now it is commonly referred to as a PEG. My involvement with the development of this technique, and the tube itself, came out of an unfortunate experience. Dr. J. Kent Hamilton and I had fi nished placing a PEG that was manufactured by the company when the patient developed stridor. He was blue. I'm sure he had very low oxygen saturation, but we had no pulse oximetry back then. When we examined the patient, we realized that the crossbar had popped off the end of the PEG and was lodged above the vocal cords. We removed the crossbar endoscopically, and the patient did fi ne. I was angry.
I immediately called the company and told them their PEG was defective and dangerous. Despite my anger at the time, I subsequently developed a longstanding relationship with the company. Th is resulted in our participating in animal studies using new PEG tubes with only one piece. Th e engineers would fl y in from Boston, and we would spend an afternoon working on animals and placing multiple PEGs, looking for failures. Subsequently, I became a member of the Institutional Animal Care and Use Committee and, for the past 10 years, have been its chairman. Th is all happened because of a crossbar falling off of a poorly manufactured PEG tube.
Also around this time, Dr. Reed Hogan II and I embarked upon a study comparing two diff erent methods of placing PEGs. We recruited many patients from a local rehabilitation hospital. Th is led to a publication entitled "Percutaneous Endoscopic Gastrostomy-to Push or to Pull: a Prospective Randomized Trial," published in Gastrointestinal Endoscopy. Th is was my fi rst GI publication.
While working in the animal lab, I found an automated TruCut needle that was used for prostate biopsies. We used this on the animals to do some liver biopsies while we were replacing PEG tubes. Subsequently, further developments occurred, and that automated TruCut needle is now commonly used to perform liver biopsies.
Th e fi rst balloon catheter was invented by Fogarty in 1963. Everybody knows that Dr. Hogan and I were the fi rst GI fellows to use the through-the-scope balloon dilators. What they do not know is that this experience almost resulted in Dr. Hogan losing his fellowship. Th is is a long story that had to do with our relationship with other institutions and the use of novel devices.
Also, early in my career, gastric bubbles were approved by the Food and Drug Administration. Th ese were bubbles made of plastic that were fi lled with air and placed into patients' stomachs for the treatment of obesity. Th e idea was that gastric bubbles would cause early satiety and decrease food intake. Dr. John Fordtran never allowed us to use gastric bubbles because he said, "At Baylor, we take out bezoars." In fact, I had the only bubble at Baylor which I kept in my desk drawer. I was dying to put it in somebody! Gastric bubbles did not go very far. In a study he conducted after his fellowship, Dr. Hogan showed that they were ineff ective in causing weight reduction.
BUMC's gastroenterology department was the fi rst to do a study using disposable biopsy forceps. Initially, forceps came Thirty years of innovation in gastroenterology: a personal history
with the scope and were reprocessed with each scope. Th is made sense since you only needed one forceps to do a procedure. You would wash off the forceps when you washed off the scope. Times change. When the idea of disposable, single-use forceps was introduced, we demonstrated that the fi rst disposable biopsy forceps made entirely of plastic were worthless for obtaining adequate tissue specimens. Th ey were also diffi cult to use. Subsequently, better forceps were developed and are now commonplace. Reusable forceps are no longer supplied with the scopes.
We spent a short while working with the idea of disposable scopes. Th e fi rst attempts placed plastic sheaths on fi ber optic scopes. Th ey were very awkward to use, and ultimately, the sheathed colonoscopes did not stay on the market. However, sheathed fi ber optic fl exi-sig scopes were accepted on the market for a while. We actually had one in the offi ce. Once video endoscopy came out, we looked at disposable video scopes. However, they could not be manufactured at a price that would compete with buying a scope and reprocessing it. Disposable video scopes did not persist on the market for long.
During one of my visits to a company interested in developing new endoscopic technology, they asked me what I thought about the idea of trying to put a hemorrhoid band on esophageal varices. I told them that I thought they were crazy, that it would be impossible as patients would not sit still for something like that, and it was a bad idea. Besides, sclerotherapy worked. A few months later, the Steigman-Goff endoscopic band ligator came out, and I had to eat my words. Sclerotherapy is now no longer taught to GI fellows.
I was the fi rst at BUMC to perform endoscopic band ligation of esophageal varices. Th e fi rst patient for whom I used band ligation was from Mexico. He did great. Later, he and his doctor had me travel to Mexico to perform band ligation on a large number of cirrhotic patients who had been waiting a long time for the procedure. I cannot recall how many patients we treated, but we learned a lot about potential scope turnaround time when you are motivated. Th e fellow was in charge of scope reprocessing. It was also an experience trying to do band ligation with suction provided only by a little pump sitting on the fl oor, not to mention the complete absence of intravenous access or anesthesia assistance. Th is was a long time ago in a land far away.
Th e fi rst transjugular intrahepatic portosystemic shunt (TIPS) was performed at BUMC around 20 years ago because we had a lot of problems with portal hypertension at that time. We still do. Th e story about the TIPS procedure is that it was fi rst done in San Antonio. Th en, one of our interventional radiologists said he would like to try it at BUMC. An interesting thing is that this conversation occurred at a party at a vascular surgeon's home. I told the radiologist that if I had a case, it would a nontransplantable patient. A few months later, we found one. It took the interventional radiologists 2 days to place their fi rst TIPS. Now it takes only several hours.
Early in my career, I was anxious for BUMC to begin doing endoscopic ultrasound. I made several trips to the Medical University of South Carolina and studied under Dr. Rob Hawes, which was the beginning of a long-lasting relationship. He was an excellent teacher, and I felt quite confi dent in bringing the technology back to BUMC. After performing endoscopic ultrasound for 5 years, it became apparent that the standard of practice would be for endoscopists to do an additional year of fellowship training in advanced endoscopy and endoscopic ultrasound. Given this and the fact that I was reluctant to return to fellowship, I gave up the art of endoscopic ultrasonography, although only after acquiring new associates who had completed a full year of additional training. However, I still enjoy watching an occasional endoscopic ultrasound. I also taught the cardiologists how to pass the transesophageal echocardiography (TEE) probe. Dr. Charles Gottlich and I were the fi rst at BUMC to do (and have) a TEE. He wanted to go fi rst, but he could not choke down the probe. So I went ahead and did it on myself. He said that we were now brothers and that I could no longer eat pork! We started to evaluate endoscopic antirefl ux procedures. Th e fi rst one was referred to as the EndoCinch procedure or endoluminal gastric plication. Th is consisted of having a little sewing machine at the end of an endoscope. I traveled to Memphis and learned the technique under Dr. Rich Rothstein. It occurred to me that I might be in the crosshairs of laparoscopic surgeons if I was taking cases from them and doing this procedure instead of laparoscopic Nissens. To accommodate the diff ering patient needs, we started the Baylor Heartburn Center to provide both endoscopic and laparoscopic solutions for intractable heartburn. We made multiple presentations to the public, with most attendees being people seeking free food and medical advice. I like to think the advice was better than the food. One seminar was scheduled to take place on 17 Roberts on the evening of September 11, 2001. We canceled it for obvious reasons. Th ere were some upset and hungry potential attendees.
Th e Baylor Heartburn Center proved to be a dramatic success and, over the course of a year, we performed over 70 endoluminal gastric plications and around 30 or 40 laparoscopic Nissens. Th e endoscopic gastric plication technology, though, proved to be short-lived and was replaced by Enterex, a polymer injection at the lower esophageal sphincter. Th is was also short-lived as it was associated with multiple complications, but not before we were able to establish our place as a center of excellence for it. However, because of funding, the technology was withdrawn from the market. Subsequently, we adopted a technique called the NDO Plicator. Th is endoscopic antirefl ux procedure was quite eff ective, but also suff ered the same fate of not obtaining a procedure code and not getting reimbursed. Th e company went bankrupt, and Th e Heartburn Center wound down.
About the same time, small-bowel capsules came into view. Th e staff and space that was devoted to the Heartburn Center was converted to the Capsule Endoscopy Center. We were the fi rst gastroenterologists in the area to do capsule enteroscopy, and this led to the need to scope the small bowel to treat the pathology found with capsule enteroscopy. Subsequently, doubleballoon enteroscopy was developed. I went to Philadelphia to learn how to do this under Dr. Oleh Haluska and really enjoyed the technology and our relationship.
Fortunately, at this time, we also moved the GI lab to the fi rst fl oor of the Truett-Johnson area. I dreamed about the fl oor plan every night. Just before completion, one of our nurses pointed out that I, along with the team of hospital architects, had forgotten to include a laundry chute. We squeezed one in at the last minute and it dumped right into vice president Dr. Irving Prengler's offi ce downstairs. Oh well.
By this time, I was established as the medical director of endoscopy, and Dr. Rick Boland was chief of gastroenterology. He gave me lots of freedom, since he was focused on fi nding a cure for colon cancer. Th e double-balloon enteroscopy required a Fujinon endoscopy system, and we had no Fujinon setups when we moved the GI lab down to the fi rst fl oor. Since we still had two new rooms to fi nish, we chose to put Fujinon in these two rooms. Th is made double-balloon enteroscopy possible at BUMC at a time when the technology was gaining wide acceptance.
We also did some single-balloon enteroscopy and, subsequently, spiral enteroscopy became available. With spiral endoscopy, we could "rotate" our way through at least 50% of the small bowel in 20 to 30 minutes. I am still working on new methods in this area and have been able to get the entire small bowel examined in fi ve patients in approximately 25 minutes using a motorized scope. I subsequently became the lead investigator for the development of power spiral enteroscopy, working mostly off shore. Th is resulted in many international excursions and subsequent cycles of antibiotics for me.
We then started to look at ways to treat Barrett's esophagus. Radiofrequency ablation for gastroenterology became available and, prior to doing my fi rst case at BUMC, I journeyed to Houston to watch a case done by my friend Dr. Isaac Raijman. Th e best part of this was the trip itself because, by that time, I was fl ying my own plane.
Polyps are hidden behind folds, and a new technology called the Th ird Eye was developed. Th is was also known as an auxiliary retrograde viewing device. We were part of the early studies, and this resulted in several publications that gave our fellows a lot to do in their spare time. Despite the fact that we demonstrated that more polyps could be found using the Th ird Eye, the technology has still not taken off because of reimbursement issues. In an eff ort to overcome this, I made several trips to the headquarters of the Centers for Medicare and Medicaid Services outside of Washington, DC. It is a huge place with very tight security, although I am not exactly sure what they are protecting.
From a practice standpoint, I was one of the fi rst to establish outreach programs because I had colleagues who had built up internal medicine practices in Ellis County. I started going there on my afternoon off . Subsequently, a full practice developed, and I felt too busy to be in two places at once. I hired another physician to work in Ellis County, but when he did not treat the practice well, Digestive Health Associates of Texas (DHAT) left Ellis County.
Th e interesting thing about the formation of DHAT, which is one of the nation's largest GI groups, was that it actually started with a conversation over a six-pack among three of us (Dr. Dan Polter, Dr. Tom Rogoff , and myself ) meeting at a gastroenterologist's house one evening. Dr. Larry Schiller came up with the name for DHAT, focusing on digestive health rather than digestive disease. I sincerely believe the formation of DHAT would not have been possible without Dr. Dan Polter. He was so well respected and trusted around the Dallas area that he was able to single-handedly recruit the practices that now make up DHAT. Once established, DHAT took on a life of its own. Dr. Dan Polter and I are no longer involved with running the practice, but it has been a pleasure to see DHAT evolve into one of the premier GI practices in the US.
Overall, my GI career has been a tremendous experience. I greatly enjoyed teaching all the fellows and participating in the development of this new technology. I thank all of my mentors, and I also thank all of my students.
